DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
The upcoming earnings report for XRAY is scheduled for Monday, May 4th, with a consensus estimate EPS of 0.28.
Diving into XRAY's performance, the current price stands at $11.79, reflecting a decrease of 17.5 cents (-1.46%) from the previous close. Trading volume is at $711,407, representing a 15.9% deviation from the average.
XRAY's latest quarterly earnings were reported on Wednesday, February 25th, with an EPS of 0.27, slightly below the consensus estimate of 0.28.
XRAY offers a forward dividend yield of 5.43%, with a dividend per share MRQ of 16 cents and a TTM of 48 cents.
The company's operating cash flow stands at $101 million, with a net change in cash of -$37 million for the period. Debt repayment amounted to $65 million, impacting the cash position.
XRAY reported a net loss of $146 million, translating to an EPS of -73 cents, with revenues totaling $961 million and gross profit at $443 million.
Key ratios for XRAY include a gross profit margin of 46.1%, operating profit margin of 27.89%, and a return on equity of -10.9%.
XRAY shows total assets of $5.43 billion, total liabilities of $4 billion, and a net debt of $2.14 billion.
This comprehensive financial snapshot of XRAY provides insights into its performance and financial health.